The Institutional Biosafety Committee is administered by the Office for Research Ethics & Compliance and provides independent oversight of all research at The University of Alabama that involves recombinant or synthetic nucleic acids, biohazardous materials, or other biological agents.
The IBC ensures that such work complies with the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules and other applicable regulations. The IBC’s authority is regulatory and advisory, it reviews research for compliance and safety standards but does not direct or manage investigators’ scientific activities.
Understanding the Role of the IBC
The Institutional Biosafety Committee is a federally regulated compliance body established under the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules.
Its primary purpose is to ensure that research involving biohazardous materials, recombinant or synthetic nucleic acids, and other biological agents at The University of Alabama is conducted safely, ethically, and in full compliancewith applicable federal, state, and institutional standards.
At UA, the IBC operates under the authority of the Vice President for Research & Economic Development through the Office for Research Ethics & Compliance.
It functions independently of colleges, departments, and investigators, and its composition, scope, and authority are defined by the NIH Office of Science Policy (OSP).
IBC Independence and Decision-Making Authority
The IBC’s decisions are based on scientific risk assessment, regulatory standards, and biosafety best practices,not on convenience, workload, or funding considerations.
- The IBC’s authority is regulatory, not advisory to individual faculty.
- Faculty, staff, or administrators may not coerce, intimidate, retaliate, direct, pressure, or override IBC committee members or their determinations regarding research approvals, containment levels, or safety requirements.
- Any attempt to pressure, intimidate, or improperly influence IBC members or their decisions is strictly prohibited. Such actions may result in disciplinary review, suspension of research privileges, and, if warranted, referral to federal oversight agencies. Regulatory consequences to the University include:
- Suspension or revocation of the University’s IBC registration;
- Suspension of the University’s review of UA research involving recombinant or synthetic nucleic acids; or
- Restriction or termination of NIH funding for affected projects or the institution as a whole.
Roles and Responsibilities
- Investigators are responsible for providing accurate and complete descriptions of proposed research, including all biological materials and methods.
- The IBC evaluates those submissions to confirm that containment practices, training, and facilities meet required biosafety standards.
- EHS (Environmental Health & Safety) provides operational biosafety support and implements laboratory-level safety training and inspections.
- OREC (Office for Research Ethics & Compliance) administers the IBC, maintains official records, and ensures alignment with NIH reporting and documentation requirements.
Why the IBC’s Independence Matters
The IBC’s independent oversight protects:
- The safety of researchers, students, and staff working with biohazards;
- The integrity of The University of Alabama’s research programs; and
- The trust of funding agencies, regulatory partners, and the public.
The IBC’s role is not to inhibit research, but to ensure that all biological research at UA is conducted responsibly, transparently, and in compliance with national biosafety standards.
Faculty participation and collaboration with the IBC are encouraged and valued, but compliance determinations are not negotiable.
The Biological Safety Program, managed by Environmental Health & Safety (EHS), provides operational safety support, including laboratory inspections, training, and incident response. While EHS focuses on how research is conducted safely, the IBC (through ORED) focuses on whether proposed work meets required containment and compliance standards.
Together, ORED and EHS work collaboratively to help UA researchers conduct innovative science safely, responsibly, and in full compliance with federal and institutional expectations.
Scope of IBC Review
The University of Alabama’s IBC is responsible for reviewing and approving all research and instructional activities that involve recombinant or synthetic nucleic acid molecules, biohazardous agents, human or animal materials that may contain infectious agents, and other biological hazards as defined in the NIH Guidelines.
The IBC evaluates each project to determine the appropriate risk group (RG1–RG4) classification and containment level (BSL-1 or BSL-2 at UA) and ensures that investigators have met all training, facility, and procedural requirements before work begins.
UA currently authorizes research involving Risk Group 1 and 2 organisms. Proposals involving Risk Group 3 materials, select agents, or gene-drive–modified organisms require prior consultation with the Biosafety Officer in Environmental Health & Safety (EHS) to assess feasibility and containment.
Through this review process, the IBC supports safe, compliant, and innovative biological research while maintaining alignment with NIH, CDC, and institutional standards.
Training & Resources
All faculty, staff and students working with biohazardous materials or recombinant/synthetic nucleic acids must complete the required biosafety training within 60 days of IBC registration and prior to initiating work.
Baseline IBC/Biosafety training is required for all investigators, staff, students, and visiting scientists listed on an approved IBC protocol. The training covers safe laboratory practices, regulatory responsibilities, risk assessment, and emergency procedures for work involving recombinant or synthetic nucleic acids and other biohazards. The required course, “Initial Biosafety Training” is delivered through the CITI Program. This training must be renewed every three (3) years and satisfies the Institutional Biosafety Committee’s (IBC) baseline training requirement.
Depending on the type and risk level of the work, additional modules or certifications may be required, such as:
- Bloodborne Pathogens Training (for human or animal materials)
- rDNA and Viral Vector Modules (for gene manipulation or viral systems)
- Shipping of Biological Materials (for those packaging or transporting biohazards)
- Select Agent or Gene-Drive Training, when applicable
Environmental Health & Safety (EHS), through its Biological Safety Program, provides and tracks these trainings, conducts laboratory inspections, and advises on containment practices and personal protective equipment (PPE).
The Office for Research Ethics & Compliance (OREC) ensures that IBC training requirements are met for protocol approval and coordinates with EHS to confirm compliance with the NIH Guidelines. The Biological Safety Program, managed by EHS, provides additional biosafety and laboratory safety training through Skillsoft, conducts inspections, and assists researchers with operational safety practices.
Institutions that receive NIH funding for research involving recombinant or synthetic nucleic acid molecules must comply with the NIH Guidelines. Even if only one project benefits from NIH support, all similar research conducted at UA must follow the NIH Guidelines.
Training completion must be verified before the IBC grants final approval for any protocol.
For Training:
- CITI Program – Biosafety and IBC Training Modules
- NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules:
- Centers for Disease Control and Prevention (CDC) – Biosafety in Microbiological and Biomedical Laboratories (BMBL)
Membership & Meetings
The Institutional Biosafety Committee (IBC) operates as an independent oversight body appointed by the Institutional Official (IO), the Vice President for Research & Economic Development or their designee, in accordance with the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules.
The Committee is composed of at least five members who collectively possess the scientific expertise, biosafety experience, and community representation necessary to evaluate the risks of research involving biological materials.
- At least two members are unaffiliated with the University, representing community interests in health and environmental protection.
- A Biosafety Officer (BSO), housed within Environmental Health & Safety (EHS), serves as a voting member.
- UA requires that faculty members appointed to the IBC hold tenure, ensuring experienced, objective, and stable governance in the review of biological research.
Members are appointed for staggered terms and must complete required biosafety and conflict-of-interest training prior to participating in reviews. Member biosketches and roster updates are filed annually with the NIH Office of Science Policy (OSP).
The IBC meets monthly, and members typically devote an average of 7–10 hours per month to committee service, including meeting attendance and review of research protocols. Additional ad hoc reviews may be requested between meetings for urgent amendments or time-sensitive projects.
Through their service, IBC members play a critical role in supporting safe, compliant, and innovative research at The University of Alabama.
IBC Meetingsare scheduled on the first Tuesday of the month unless otherwise arranged.
Interested in Serving on the IBC?
Who Can Serve
- The IBC must have at least five members with collective expertise to assess risks associated with recombinant or synthetic nucleic acid research.
- At least two members must be unaffiliated with The University of Alabama and represent community interests in health and environmental protection.
- The roster must include (or have ad hoc access to) relevant expertise (e.g., plant, animal, and human containment).
- A Biosafety Officer (BSO) must be a member if the institution conducts large-scale work, BL3/BL4 research, or work involving gene-drive modified organisms.
- Faculty members serving on the IBC must hold tenure to ensure an experienced, independent, and stable governance perspective in committee deliberations.
- (Source: NIH Office of Science Policy, NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules.)
How Members Are Appointed
- Members are appointed by the Institutional Official (IO), the Vice President for Research & Economic Development (or designee).
- UA files an annual roster and member biosketches with the NIH Office of Science Policy (OSP).
- Members do not review projects in which they are involved or have a direct financial interest, consistent with federal conflict-of-interest standards.
Time & Expectations
- Attend regular IBC meetings and participate in protocol review.
- Complete required biosafety, confidentiality, and conflict-of-interest attestations.
- Training and orientation are provided; ad hoc consultants may supplement expertise when needed.
Typical time commitment: IBC members generally attend a 90-minute monthly meeting and spend an additional 7–9 hours reviewing protocol materials in advance. The total annual time commitment averages approximately 7–10 hours per month, including meeting attendance, review preparation, and brief online compliance attestations.
Meeting Attendance and Quorum Requirements
Regular attendance is essential to the function of the Institutional Biosafety Committee (IBC).
Because the IBC operates under federal oversight (NIH Guidelines), each meeting must maintain a formal quorum of voting members in order to review and approve research protocols.
If quorum is not met, the committee cannot conduct official business, including review or approval of new or continuing research.
Consistent participation ensures:
- Compliance with NIH and institutional regulations;
- Timely review of research protocols; and
- Fair workload distribution among members.
IBC members are expected to:
- Attend monthly meetings (typically 60–90 minutes);
- Notify the IBC Administrator in advance if unable to attend; and
- Complete pre-meeting protocol reviews in a timely manner.
Repeated absences may require replacement of the member to preserve the committee’s ability to meet federal quorum and review requirements.
How to Volunteer for Consideration
- Email the IBC Administrator, Erica Chapin, at emchapin@ua.edu with:
- A brief statement of interest and areas of expertise;
- A current CV; and
- Whether you are a community (unaffiliated) or UA-affiliated candidate.
- UA maintains a candidate pool and fills openings based on required expertise and NIH composition rules.
- Roster updates are posted and filed with the NIH OSP annually.
For more information, contact the Institutional Biosafety Committee (IBC) at ibc@ua.edu.
Office for Research Ethics & Compliance, The University of Alabama.
Contact
The University of Alabama is committed to supporting safe and compliant biological research through collaboration between the Office for Research Ethics & Compliance (OREC) and Environmental Health & Safety (EHS). Please contact the appropriate office for assistance, depending on your question or need:
Institutional Biosafety Committee (IBC)
Office for Research Ethics & ComplianceOREC oversees the administration of the IBC, which oversees protocol review, training verification, and compliance with the NIH Guidelines.
ibc@ua.edu
(205) 348-5152
Office for Research Ethics & Compliance
Box 870127
Tuscaloosa, AL 35487
Biological Safety Program
Environmental Health & Safety (EHS)Provides operational biosafety support, training, laboratory inspections, and incident response.
Biological Safety Officer (BSO): Cynthia Rodenburg, RBP (ABSA)
biosafety@ua.edu
(205) 348-5941